States to get Covishield vaccine at Rs 400, pvt hospitals at Rs 600 a dose

Serum said its vaccine, which it manufactures as a partner of Britain's AstraZeneca, is "affordable to any other" in the world

Covishield
Covishield (Photo: PTI)
BS Web Team New Delhi
2 min read Last Updated : Apr 21 2021 | 1:29 PM IST
State governments will get the Covishield vaccine at Rs 400 a dose and private hospitals at Rs 600, said the Serum Institute, which manufactures the inoculation against Covid-19. The price for central government stays at Rs 150.

Serum said its vaccine, which it manufactures as a partner of Britain’s AstraZeneca, is "affordable to any other" in the world. The company listed its prices two days after the government decided to open up vaccinations against Covid-19 to those aged 18 and above.

"For the next two months, we will address the limited capacity by scaling up the vaccine production. Going ahead, 50 per cent of our capacities will be served to the government of India's vaccination programme, and the remaining 50% of the capacity will be for the state governments and private hospitals," said Serum on Twitter.

Covishield comprises more than 90 per cent of the 12.76 crore Covid-19 vaccines administered in India so far, a PTI report said quoting government data on Wednesday. As many as states and union territories have only given Covishield. 

The single-day rise in new coronavirus infections inched closer to 3 lakh on Wednesday, pushing India's total tally of Covid-19 cases to 1,56,16,130, while the death toll increased to 1,82,553 with a record 2,023 daily fatalities.

As the country grapples with a worrying second wave of coronavirus infections, Prime Minister Narendra Modi on Wednesday appealed to states that lockdowns should be the last option. In a hurriedly called address to the nation late Tuesday evening, the PM said economic activity and livelihood must remain least impacted.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownCoronavirus VaccineSerum Institute of India

Next Story